Advertisement
Screener

Adhera Therapeutics, Inc. Deferred Revenue Recognized

Adhera Therapeutics, Inc. Deferred Revenue Recognized

Adhera Therapeutics, Inc. reported Deferred Revenue Recognized of -$200.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2019-05-15.

Discontinued › Income Statement › Other Income

us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2019-05-15

  • Adhera Therapeutics, Inc. contract with customer, liability, revenue recognized for the quarter ending 2018-03-31 was -$200.00K.
Period endContract with Customer, Liability, Revenue Recognized 3 month
2018-03-31-$200.00K
10-Q · filed 2019-05-15